Physician

Richard S Kaiser, MD

According to 2025 Medicare claims, Richard Kaiser, MD (NPI: 1124076930) practices ophthalmology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 18017-9412.

Kaiser's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,539 traditional Medicare patients, billed 42,766 HCPCS/CPT codes, and received $6,789,362 in Medicare payments. The top billing code was Q5128 (Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg). Part D data shows 305 prescription claims across 118 beneficiaries totaling $30,473 in drug costs, led by Brimonidine Tartrate (Brimonidine Tartrate). Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $40,162 to $30,473. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$4.3M$8.6M2015 Medicare payment: $7,877,221 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $8,602,528 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $8,135,583 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $8,315,622 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $7,812,834 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,809,660 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $7,205,646 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,750,542 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,630,735 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,789,362 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,97934,645$7,877,221
20161,93938,042$8,602,528
20171,84135,746$8,135,583
20181,91939,801$8,315,622
20191,84437,736$7,812,834
20201,50432,739$6,809,660
20211,56834,810$7,205,646
20221,62936,062$6,750,542
20231,56738,421$6,630,735
20241,53942,766$6,789,362

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$46K2015 Drug cost: $40,162 (USD; Tot_Drug_Cst)2016 Drug cost: $42,554 (USD; Tot_Drug_Cst)2017 Drug cost: $38,157 (USD; Tot_Drug_Cst)2018 Drug cost: $45,515 (USD; Tot_Drug_Cst)2019 Drug cost: $22,511 (USD; Tot_Drug_Cst)2020 Drug cost: $30,612 (USD; Tot_Drug_Cst)2021 Drug cost: $19,584 (USD; Tot_Drug_Cst)2022 Drug cost: $17,907 (USD; Tot_Drug_Cst)2023 Drug cost: $12,144 (USD; Tot_Drug_Cst)2024 Drug cost: $30,473 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015167420$40,162
2016153358$42,554
2017148355$38,157
2018138368$45,515
2019126287$22,511
2020117352$30,612
2021132293$19,584
2022132306$17,907
2023125287$12,144
2024118305$30,473

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg52618,370$181
67028Injection of drug into eye7844,377$105
92014Established patient complete exam of visual system575658$90
92012Established patient problem focused exam of visual system8743,179$70
92134Imaging of retina1,4945,410$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Brimonidine TartrateBrimonidine Tartrate141,164$4,212
Prednisolone AcetatePrednisolone Acetate963,552$4,181
Bromfenac SodiumBromfenac Sodium21567$3,017
EplerenoneEplerenone13735$1,115
Ketorolac TromethamineKetorolac Tromethamine612,032$761

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$15Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Richard S. Kaiser, MD?

Tedicare shows public-source Medicare data for Richard S. Kaiser, MD (NPI 1124076930), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard S. Kaiser, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard S. Kaiser, MD?

Richard S. Kaiser, MD is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Richard S. Kaiser, MD have Open Payments data?

Richard S. Kaiser, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.